Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

121.48
Delayed Data
As of 4:00pm ET
 -1.53 / -1.24%
Today’s Change
108.50
Today|||52-Week Range
160.00
-13.57%
Year-to-Date
Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial
Sep 28 / Zacks.com - Paid Partner Content
The Cheapest Stocks in Biotech
Sep 23 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close123.01
Today’s open123.07
Day’s range121.08 - 123.58
Volume721,438
Average volume (3 months)740,715
Market cap$7.4B
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+6.57%
Earnings growth (next 5 years)+15.76%
Revenue growth (last year)+12.95%
P/E ratio21.3
Price/Sales6.69
Price/Book4.72

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.79+1.15%
SGENSeattle Genetics Inc+0.72+1.35%
ALKSAlkermes Plc+0.32+0.69%
RDYDr.Reddy's Laborator...+0.18+0.39%
Data as of 4:04pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$2.61
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs